
Physician-scientist specializing in mineral balance and #hypertension. #magnesium #potassium #photography. Tweets are my own views.
Pittsburgh, PA
Joined January 2020
- Tweets143
- Following216
- Followers208
- Likes174
Evan Cross Ray retweeted
So excited to announce publication of our new research manuscript in @CircRes on “DC ENaC-Dependent Inflammasome Activation Contributes to Salt-Sensitive Hypertension”👇🏿
ahajournals.org/doi/10.1161/…
Congrats 1st author @ashleylpitzer! Big Thanks to Co-authors
PPI's in CKD: 3 pts in CKD clinic with PPIs restarted since I held them previously (usu adding an H2B) Indications: GERD (by GI), cough/COPD (by Pulm). None for Barret's or GI erosion. Frustrated my colleagues in other specialties and I are working against ea. other. Thoughts?
Evan Cross Ray retweeted
#FreeArticleOfTheWeek- L-WNK1 is required for BK channel activation in #IntercalatedCells
By: Evan C. Ray, et al.
ow.ly/rmKR50GUEKM
#AJPRenal #WNK1Kinase @PittDeptofMed @RayRenal @mohd_bataineh @tkleyman @arohan_s
Evan Cross Ray retweeted
If people wonder why I keep switching patients from short-acting furosemide to longer-acting torsemide, it’s because of the top graph.
Green bar above dashed line (na excretion from furosemide) rapidly approaches pink area (compensatory reabsorption)—>0 net naturiesis.
🟢Renal Na+ avidity, the prevailing renal target in heart failure @ESC_Journals @ehj_ed @PieterMartensMD @WilsonTangMD #CardioEd #Cardiology @Cardioinfo_it @APCyCCV @SACardiologia @VietHeartPA @Hragy @SolovevaAnzhela @gonzaeperez @noshreza @ShelleyZieroth @torresviera @SVCardio
"To clean the urine is to clean the soul, and the mind..."
youtube.com/shorts/1aw4LRDKU…
"And what of the urine? Does he still produce that liquid that maintains our feeble balance with nature?"
Could have been a scene with one of my medical school attendings. But now I realize... I have become that attending...
youtu.be/1aw4LRDKUXM
Amazing headline from the day after the Tulsa massacre, in which hundreds of black Americans were killed, and 10,000 were left homeless.
Evan Cross Ray retweeted
SQ Mag? Weekly SGL2Ti ? Mag Lactate or Aspartate, better oral availability!
@RayRenal gave a master class “Old and new therapeutic approaches to #hypomagnasemia” at #NKFClinicals #Nephpearls #NephTwitter #Nephnuggets #1440club @PITTRenal #MedEd #MedTwitter #KidneyAide – at Batesville, SC
Interesting report on how low Mg contributes to salt-sensitive #hypertension from Keizo Kanasaki. Hint: it may involve COMT, SPAK, and NCC. @hyperAHA #hypomagnesemia
ahajournals.org/doi/pdf/10.1…
Evan Cross Ray retweeted
Our invited comprehensive paper on #inflammation and #immunity in #hypertension is now published @CircRes!
ahajournals.org/doi/pdf/10.1…
Thanks co-authors @CVimmunology @isjaima @Dr_AshleyPitzer @tkleyman @Jvanbeusecum @smartdunc @RobNPeck @VascRes @VUMChealth @VUMCClinPharm
Check out our recent mega review on inflammation and hypertension. True team effort. @annetkiraboc1 @CircRes @VUMC_heart @VUMC_Medicine @VascRes #Cardioimmunology #hypertension ahajournals.org/doi/10.1161/…
Evan Cross Ray retweeted
jasn.asnjournals.org/content…
Normally, ENaC goes down on a high salt diet (no need in sodium retention). However, genetic predispostition can break this mechanism and contribute to hypertension. Check on how inflammation is involved in this process in male db/db mice #KidneyInCVD 👍
Nephrologists - is anyone routinely using hand-held #ultrasound devices on rounds to evaluate fluid volume with IVC collapse or Kerley B-lines? Which devices?
#POCUS @askrenal #nephrology
Biden: Yellen needs a “Hamilton” musical. Dessa: Here you go. marketplace.org/2021/01/21/y…
WARNING: Side effects from the COVID-19 Vaccine from Pfizer.
I got dose #2 of the Pfizer COVID-19 vaccine 3 days ago and wanted to warn you about some of the severe side effects I’m experiencing. These include
- A sore arm for 12-18 hours.
or the ones in the yogurt at the back of my fridge that has been open since Trump still endorsed Fox News; and 2) does not shield me from nausea experienced after watching the news.


















